Pennington Biomedical researchers have contributed to the Lancet Commission on Clinical Obesity, aimed at redefining the approach to diagnosing obesity as a clinical condition.
The commission is made up of a diverse group who address obesity as requiring comprehensive evaluation and treatment.
The approach proposed seeks to add depth to the definition of obesity and broadens it to include various assessments such as the measure of excess body fat.
The commission distinguishes between clinical and pre-clinical obesity, with clinical obesity describing a state where excess body fat contributes to severe disruptions in normal body functions.
This redefined classification will streamline treatment procedures and healthcare practices related to obesity.
The suggestion here signifies an unprecedented shift towards a structured medical understanding of the disease.
The center’s contribution to contemporary obesity treatment programs reflects its ongoing commitment to confronting the obesity epidemic.
Medical professionals worldwide will benefit from the organized and cohesive definition and diagnostic criteria.
The researchers advocate for systemic reforms in how obesity is perceived, diagnosed, and treated, ensuring that the latest methodologies and research findings are integrated into clinical practices.
The Lancet Commission’s work represents an emblematic shift towards an evidence-based, patient-centered strategy in tackling this pressing health crisis.